Transforming primary care practices into patient-centered medical homes (PCMHs) is increasingly seen as a way to enhance primary care. However, very little is known about the costs of these investment.
Transforming primary care practices into patient-centered medical homes (PCMHs) is increasingly seen as a way to enhance primary care. However, very little is known about the costs of these investment.
A report in the Journal of General Internal Medicine finds that the costs of transformation were significant and highly variable across practices. Furthermore, the ongoing costs of maintaining a medical home are substantially larger than the one-time costs of transformation, which is detrimental in making better investments in primary care practices.
Medical home initiatives encourage primary care practices to invest in new structural capabilities such as patient registries, care managers and information technology. If handled better, these transformation practices can largely improve the quality and efficiency of care, patient experience, and provider satisfaction. However, it is also important to consider the costs associated.
Grant Martsolf, PhD, MPH, RN, and fellow researchers interviewed practice representatives, identified the components of each practice’s transformation during the intervention, and calculated the corresponding costs.
Study Design and Results
For the study, the authors surveyed practice leaders across 12 practices in the Pennsylvania Chronic Care Initiative (PACCI), a statewide multi-payer medical home pilot. The objective was to identify the changes undertaken by practices due to medical home transformation. They also computed the costs of additional personnel and other investments associated with these changes.
Out of the 12 practices, 6 were family medicine or mixed specialty, 5 were internal medicine and 1 was pediatric only. Also, 7 were system-affiliated and 5 were small and independent practices.
The researchers found:
Tailored Subsidies to Avoid Financial Challenges
One-time costs included setting up patient registries, training and educating employees, and preparing internal policies and procedures. The ongoing transformation costs included new staff hiring, care management meetings, patient outreach through reminders and phone calls. The study highlighted the enormous costs undertaken for the transformation process, especially when the ongoing costs far exceeded one-time costs.
“Our findings suggest that medical home transformation can have especially challenging financial implications for small and independent practices, which incurred substantially higher per-clinician total transformation costs,” Martsolf said in a statement.
Transformation costs incurred at the system level are certainly not to be underestimated. Greater per-clinician subsidies to small and independent practices may be necessary if payers wish to avoid creating pressure for such practices to merge with larger delivery systems.
“Continuing experimentation, evaluation, and refinement of medical home interventions can help solidify the business case for making such investments in primary care practices,” Martsolf concluded.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More